Cyteir Therapeutics Presents Preclinical Data on Use of DNA Repair Modulators for Lymphoid Malignancies at American Society of Hematology Annual Meeting
cyteir2018-03-07T22:47:27-05:00Cyteir Therapeutics Presents Preclinical Data on Use of DNA Repair Modulators for Lymphoid Malignancies at American Society of Hematology Annual Meeting -- Preclinical data elucidates mechanism of cell death response to selectively target lymphoid cancers -- CAMBRIDGE, Mass. – November 29, 2016 – Cyteir Therapeutics, Inc., a leader in the development of novel therapeutics based on the [...]